Access the latest science & engage with your peers on social media
Follow #ESMOImmuno22 on Facebook, Twitter, LinkedIn, Instagram and YouTube.
Share the science and be part of the conversation
- The official hashtag is #ESMOImmuno22: using it will allow you to join the conversation around the Congress
- Permission is not needed to use the hashtag
- A total of two Twitter handles may be included in the ESMO Immuno-Oncology 2022 content, e.g. posters, presentations. Handles to be included can be the ones of first author/presenter and the sponsor.
- It is strongly advised to also use the Congress hashtag (#ESMOImmuno22) to allow for increased visibility and engagement during Congress.
The European Society for Medical Oncology (ESMO) welcomes discussions related to cancer issues on social media.
Statements or opinions expressed in posts reflect the views of the contributor, and do not reflect the official views of ESMO, unless otherwise noted. ESMO cannot respond to every comment. Likes and follows on social media channels are not endorsements. ESMO assumes no liability for sensitive information posted by users.